Snatch This Bargain Even Cheaper Than Chief Financial Officer Stilwell Did

There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on June 9, Coherus BioSciences Inc's Chief Financial Officer, Mcdavid Stilwell, invested $49,667.69 into 3,700 shares of CHRS, for a cost per share of $13.42..